Webbför 22 timmar sedan · Kazia Therapeutics Ltd K KZA: RECEIVED NOTIFICATION FROM LISTING QUALIFICATIONS STAFF OF NASDAQ STOCK MARKET LLC. … Webbför 18 timmar sedan · Kazia Therapeutics Limited (NASDAQ: kzia ; ASX: KZA) is an oncology-focused drug development company, based in Sydney, Australia. Our lead …
KAZIA REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID …
WebbKazia is an Australian oncology company developing innovative, high-impact drugs for cancer. Our lead program is paxalisib, which is being developed to treat glioblastoma, … Home - Kazia Therapeutics Limited About Us - Kazia Therapeutics Limited Kazia's lead programs, paxalisib and EVT801, draw on the latest advances in … For Partners - Kazia Therapeutics Limited For Patients - Kazia Therapeutics Limited At Kazia, we believe that the best thing we can do for our investors is to deliver high … Kazia Therapeutics Limited Three International Towers Level 24, 300 … Kazia Therapeutics Limited. Email: [email protected]. Mailing … Webb11 apr. 2024 · Kazia Therapeutics Limited ABN: 37 063 259 754 Reporting period: For the half-year ended 31 December 2024 Previous period: For the half-year ended 31 … howling monster
For Investors Kazia Therapeutics Limited
WebbFör 1 dag sedan · TO PAXALISIB FOR GLIOBLASTOMA Sydney, 20 August 2024 - Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused … Webb23 feb. 2024 · Interview with Dr James Garner, CEO of Kazia Therapeutics Watch video XR-17 is Vivesto’s proprietary delivery platform Learn more Press releases Regulatory … howling mine effects